Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)

H. J. Wanebo, J. Lee, B. A. Burtness, J. A. Ridge, M. Ghebremichael, S. A. Spencer, D. Psyrri, E. Pectasides, D. Rimm, F. R. Rosen, M. R. Hancock, K. A. Tolba, A. A. Forastiere

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)'. Together they form a unique fingerprint.

Medicine & Life Sciences